Flexible reverse iontophoresis-based electrochemical sensor

Flexible reverse iontophoresis-based electrochemical sensor has been studied in 1 paper since 2026: 1 observational study in people; 1 in the past year. The newest paper, Apr 10, 2026: “A Flexible Wearable Glucose Sensor for Noninvasive Diabetes Screening: Functional Equivalence and Model Interpretability”.

Intervention

1 paper studies it3 findingsUpdated

See all 1 papers on flexible reverse iontophoresis-based electrochemical sensor

At a glance

The findings reach people, from one lab or study. 1 lab in 2 countries.

“functional equivalence was confirmed (T = -6.537 < threshold = -2.081) in the general population but not in older adults or T2DM patients.”
A Flexible Wearable Glucose Sensor for Noninvasive Diabetes Screening: Functional Equivalence and Model InterpretabilityBiosensors2026doi:10.3390/bios16040214

None of its findings points the other way.

Humans: a single group. Cells, worms or flies and mice: nothing yet.
  • 1 lab in 2 countries
  • Funders: Capital's Funds for Health Improvement and Research and 1 more
  • Humans1

What is flexible reverse iontophoresis-based electrochemical sensor linked with?

3

Studies link flexible reverse iontophoresis-based electrochemical sensor with 3 measures: prediabetes, type 2 diabetes and functional equivalence.

Prediabetes

upin humans1

1 study
  1. Flexible reverse iontophoresis-based electrochemical sensor predicts prediabetes in humans (AUC = 0.760).

    “Functional principal component scores facilitated the identification of prediabetes (AUC = 0.760).”

    Human trial12-h daytime60.0% femalesn = 135

    A Flexible Wearable Glucose Sensor for Noninvasive Diabetes Screening: Functional Equivalence and Model Interpretability

    Biosensors

More on Prediabetes

Type 2 diabetes

upin humans1

1 study
  1. Flexible reverse iontophoresis-based electrochemical sensor predicts type 2 diabetes in humans (AUC: 0.906 vs. 0.850).

    “The T2DM noninvasive screening model demonstrated discrimination and reclassification performance comparable to those of the capillary-based model (AUC: 0.906 vs. 0.850, NRI: 0.044, IDI: -0.078, p > 0.05).”

    Human trial12-h daytime60.0% femalesn = 135

    A Flexible Wearable Glucose Sensor for Noninvasive Diabetes Screening: Functional Equivalence and Model Interpretability

    Biosensors

More on Type 2 diabetes

Functional equivalence

upin humans1

1 study
  1. Flexible reverse iontophoresis-based electrochemical sensor is associated with functional equivalence in the general population (T = -6.537 < threshold = -2.081).

    “functional equivalence was confirmed (T = -6.537 < threshold = -2.081) in the general population but not in older adults or T2DM patients.”

    Human trialin the general population12-h daytime60.0% femalesn = 135

    A Flexible Wearable Glucose Sensor for Noninvasive Diabetes Screening: Functional Equivalence and Model Interpretability

    Biosensors

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 1May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 01 paper in 12 months